Dr. Carmella L. Stephens has over 25 years experience counseling a wide range of clients including biotechnology and pharmaceutical corporations as well as academic institutions on issues relating to biotech and pharmaceutical patents. Her experience includes development and management of complex U.S. and foreign patent portfolios based on assessment of the client’s business interests.
Dr. Stephens has prepared and prosecuted hundreds of patent applications (US and foreign) in a number of complex biotech and pharmaceutical fields. Her patent prosecution has included conducting interviews in the USPTO resulting in the successful issuance of patents. She has successfully obtained strategic patent protection for clients, in some cases, leading to favorable settlement and cross-licensing as an alternative to litigation.
Dr. Stephens’ patent practice covers an array of different life science technologies including those relating to genome editing systems including TALEN and CRISPR/Cas9 endonuclease based systems; development and use of therapeutic antibodies, immunotherapeutics based on T-cell reactivity against tumor cells; diagnostic and prognostic tests based on gene expression profiles; viral based expression systems for use in gene therapy; transgenic animal model systems; attenuated viruses for use as vaccines; development and use of stem cells and treatment of diseases including familial hypercholesterolemia, ocular disorders, cardiac disorders and Alzheimer’s disease.
Prior to pursuing a legal career, Dr. Stephens received her Ph.D. from SUNY Stony Brook after completion of her thesis research at Cold Spring Harbor Laboratory followed by a post-doctoral fellowship conducted at Memorial Sloan Kettering Cancer Center.
EDUCATION • J.D., Fordham University School of Law • Ph.D., Cold Spring Harbor Laboratory / SUNY Stony Brook • B.S., Adelphi University
ADMISSIONS • New York • U.S. Patent and Trademark Office • U.S. District Court for the Southern District of New York